Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ADAPY

Adaptimmune Therapeutics PLC

CIK 0001621227

Health CareBiological Products, (No Diagnostic Substances)
$0.03
↑ 0.00 (0.00%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$42.94M
P/E Ratio
-0.25
EPS
-0.05
Dividend Yield
Not covered
52W Position
49%
Beta
-1.11

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-0.61
P/S
0.66
EV/Revenue
0.65
ROE
239.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

63 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 49%
$0.01$0.05

Latest Financials

2024-12-31 FY
Revenue
$178.03M
Net Income
-$70.81M
Total Assets
$245.96M
Free Cash Flow
-$74.09M

Recent news